Back to calendar
NewAmsterdam Pharma Company N.V. (NAMS) Earnings
NAMS reports earnings on Wednesday, August 12, 2026
earnings report
August 12, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.48
Actual EPS: $-0.40
EPS surprise: 12.85%
Company overview
Market Cap$3.8B
PriceUSD 32.20
EPS (TTM)-1.80
52-week high42.20
52-week low20.53
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees100